AAAAAA

   
Results: 1-10 |
Results: 10
Lipid oxidation enhances the function of activated protein C
Authors: Safa, O Hensley, K Smirnov, MD Esmon, CT Esmon, NL
Citation: O. Safa et al., Lipid oxidation enhances the function of activated protein C, J BIOL CHEM, 276(3), 2001, pp. 1829-1836
Antiphospholipid antibodies and the protein C pathway
Authors: Esmon, NL Safa, O Smirnov, MD Esmon, CT
Citation: Nl. Esmon et al., Antiphospholipid antibodies and the protein C pathway, J AUTOIMMUN, 15(2), 2000, pp. 221-225
Surface expression and functional characterization of alpha-granule factorV in human platelets: effects of ionophore A23187, thrombin, collagen, andconvulxin
Authors: Alberio, L Safa, O Clemetson, KJ Esmon, CT Dale, GL
Citation: L. Alberio et al., Surface expression and functional characterization of alpha-granule factorV in human platelets: effects of ionophore A23187, thrombin, collagen, andconvulxin, BLOOD, 95(5), 2000, pp. 1694-1702
IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome
Authors: Safa, O Crippa, L Della Valle, P Sabbadini, MG D'Angelo, SV D'Angelo, A
Citation: O. Safa et al., IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome, HAEMATOLOG, 84(9), 1999, pp. 829-838
Lupus anticoagulants, thrombosis and the protein C system
Authors: Esmon, NL Smirnov, MD Safa, O Esmon, CT
Citation: Nl. Esmon et al., Lupus anticoagulants, thrombosis and the protein C system, HAEMATOLOG, 84(5), 1999, pp. 446-451
Interference of lupus anticoagulants in prothrombin time assays: implications for selection of adequate methods to optimize the management of thrombosis in antiphospholipid-antibody syndrome
Authors: Della Valle, P Crippa, L Garlando, AM Pattarini, E Safa, O D'Angelo, SV D'Angelo, A
Citation: P. Della Valle et al., Interference of lupus anticoagulants in prothrombin time assays: implications for selection of adequate methods to optimize the management of thrombosis in antiphospholipid-antibody syndrome, HAEMATOLOG, 84(12), 1999, pp. 1065-1074
Relocating the active site of activated protein C eliminates the need for its protein S cofactor - A fluorescence resonance energy transfer study
Authors: Yegneswaran, S Smirnov, MD Safa, O Esmon, NL Esmon, CT Johnson, AE
Citation: S. Yegneswaran et al., Relocating the active site of activated protein C eliminates the need for its protein S cofactor - A fluorescence resonance energy transfer study, J BIOL CHEM, 274(9), 1999, pp. 5462-5468
Inhibition of activated protein C anticoagulant activity by prothrombin
Authors: Smirnov, MD Safa, O Esmon, NL Esmon, CT
Citation: Md. Smirnov et al., Inhibition of activated protein C anticoagulant activity by prothrombin, BLOOD, 94(11), 1999, pp. 3839-3846
Factor VIIa/tissue factor generates a form of factor V with unchanged specific activity, resistance to activation by thrombin, and increased sensitivity to activated protein C
Authors: Safa, O Morrissey, JH Esmon, CT Esmon, NL
Citation: O. Safa et al., Factor VIIa/tissue factor generates a form of factor V with unchanged specific activity, resistance to activation by thrombin, and increased sensitivity to activated protein C, BIOCHEM, 38(6), 1999, pp. 1829-1837
Morphological changes and cytokine gene expression in tumor xenografts following treatment with the alkylphosphocholines hexadecylphosphocholine and perifosine
Authors: Safa, O Parkin, SM Bibby, MC
Citation: O. Safa et al., Morphological changes and cytokine gene expression in tumor xenografts following treatment with the alkylphosphocholines hexadecylphosphocholine and perifosine, DRUGS TODAY, 34, 1998, pp. 15-26
Risultati: 1-10 |